News Archive - Page 2 of 9

15th October 2021

Global Leukaemia Patient Experience Survey Now Open!

The global leukaemia patient experience survey has been created to build a global picture of the experiences of people with ALL, AML CLL and CML and their carers, friends and family and the aim is to understand the key issues, experiences and unmet needs for leukaemia patients.

24th September 2021

Leading leukaemia charities call on Rishi Sunak not to cut lifeline for blood cancer patients currently on furlough

Leading blood cancer charities have today (24th September) sent a letter to Chancellor Rishi Sunak, calling on him to continue financial support for leukaemia and other blood cancer patients currently on furlough as a result of the COVID-19 pandemic.

3rd September 2021

COVID-19 vaccine programme next steps for leukaemia patients: from third doses to “spring” boosters

This article aims to explain more about different doses of the vaccine programme, from 3rd primary dose to Spring booster for the immunocompromised and who is eligible. On 21st February 2022 the Government announced that those who are elderly or clinically extremely vulnerable (CEV) would be eligible to receive another booster vaccine starting from spring this year in England, 6 months after their previous booster. This would be the 5th COVID-19 vaccine for this group. Note: As far as we are aware, all countries of the UK intend to accept the JCVI guidance for a spring booster.

2nd September 2021

Leukaemia Care and OPAAL team up for Blood Cancer Awareness Month

We've teamed up with the Older People's Advocacy Alliance (OPAAL) to raise awareness of leukaemia in the 65+ community. Find out more about our collaboration.

18th August 2021

Leukaemia Care and the UK Mastocytosis Support Group successfully campaign for patients with very rare condition to access new treatment

The National Institute for Health and Care Excellence (NICE) have made recommendations for midostaurin to become an NHS treatment option for advanced systemic mastocytosis (AdvSM) patients in England. This decision follows a 4  year  long campaign by Leukaemia Care, The UK Mastocytosis Support Group and affected patients. 

12th August 2021

Leukaemia Care takes steps to show support for the LGBTQ+ community

To show the charity's support for the LGBTQ+ community, Leukaemia Care have taken the decision to include staff members' pronouns in their email signatures. Find out more about this decision here.

14th July 2021

Many leukaemia patients face a devastating choice as ‘Freedom Day’ looms: their life or their livelihood?

“Many people living with leukaemia feel they have been forgotten about in the rush to ease COVID-19 restrictions." Here, you can find out what we are doing to help support clinically extremely vulnerable (CEV) leukaemia patients, ensuring they have a voice.

9th July 2021

Lack of awareness of COVID-19 protection puts up to half a million at risk

Leukaemia Care is 1 of 16 health charities who is calling on the Government to do more to support around half a million people who are immunocompromised or immunosuppressed, and so may be less protected by the Covid-19 vaccine.

2nd July 2021

Booster jabs for the clinically extremely vulnerable – what does this mean for me?

The Joint Committee on Vaccines and Immunisations (JCVI) have published draft recommendations on the use of third vaccine doses as booster jabs. Here, we update you on what this means for blood cancer patients.

7th June 2021

The SMC recommends aclabrutinib to become a treatment option for certain groups of CLL patients in Scotland.

The Scottish Medicines Consortium (SMC) have today made recommendations for acalabrutinib to become a treatment option for certain groups of chronic lymphocytic leukaemia (CLL) patients in Scotland.